MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,636,887 | -24.8% | 413,771 | +8.6% | 0.02% | -21.1% |
| Q2 2023 | $8,829,100 | +13.3% | 380,948 | +13.6% | 0.02% | +5.6% |
| Q1 2023 | $7,793,340 | +65.0% | 335,486 | +3.1% | 0.02% | +50.0% |
| Q4 2022 | $4,721,873 | -38.1% | 325,422 | -18.6% | 0.01% | -42.9% |
| Q3 2022 | $7,623,000 | +20.8% | 399,573 | +15.0% | 0.02% | +31.2% |
| Q2 2022 | $6,313,000 | -47.8% | 347,474 | -27.6% | 0.02% | +23.1% |
| Q1 2022 | $12,100,000 | +54.0% | 480,212 | +68.7% | 0.01% | -23.5% |
| Q4 2021 | $7,857,000 | +9.0% | 284,659 | +27.6% | 0.02% | -5.6% |
| Q3 2021 | $7,205,000 | +31.5% | 223,127 | +24.6% | 0.02% | +20.0% |
| Q2 2021 | $5,478,000 | +5.7% | 179,141 | +5.3% | 0.02% | -16.7% |
| Q1 2021 | $5,181,000 | +168.3% | 170,143 | +74.2% | 0.02% | +157.1% |
| Q4 2020 | $1,931,000 | +96.2% | 97,652 | +29.5% | 0.01% | +40.0% |
| Q3 2020 | $984,000 | +67.1% | 75,412 | +45.4% | 0.01% | +25.0% |
| Q2 2020 | $589,000 | – | 51,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
| Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
| Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
| Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
| RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
| S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
| Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
| Grace Capital | 220,769 | $7,815,000 | 1.76% |
| AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |